ArticleCell genomics2022

Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment.

Christian K Hirt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.